GoodRx Holdings (GDRX) Share-based Compensation (2019 - 2026)

GoodRx Holdings' Share-based Compensation history runs 8 years deep, the most recent figure standing at $16.5 million for Q1 2026.

• In Q1 2026, Share-based Compensation fell 13.9% year-over-year to $16.5 million; the TTM figure through Mar 2026 stood at $74.0 million (down 20.56% YoY), while the FY2025 annual figure was $76.6 million, down 22.62% from the prior year.
• Share-based Compensation came in at $16.5 million for Q1 2026 at GoodRx Holdings, down from $17.9 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $32.6 million in Q3 2023 to a low of $3.6 million in Q2 2022.
• A 5-year average of $21.7 million and a median of $21.4 million in 2025 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation tumbled 35.2% in 2022 and soared 397.14% in 2023, its largest moves.
• GoodRx Holdings' Share-based Compensation stood at $29.4 million in 2022, then slipped by 2.16% to $28.8 million in 2023, then declined by 27.17% to $21.0 million in 2024, then fell by 14.5% to $17.9 million in 2025, then declined by 7.87% to $16.5 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $16.5 million, $17.9 million, and $18.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison